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Chapter 1. Introduction
1.1. Background and Significance
Cardiovascular disease (CVD) is the leading cause of death in the United States (U.S.)
and the world (1, 22). In 2012, it was estimated that about 85.6 million adults in the U.S. had
CVD which is equivalent to more than 1 in every 3 persons (33%) (22). Furthermore, CVD
places a significant financial strain on the U.S. economy and healthcare system contributing an
estimated $316.6 billion in direct and indirect costs, making CVD one of the most costly medical
conditions (22). By 2030, the total direct medical costs attributable to CVD are projected to triple
to ~$900 billion (22). About half of U.S. adults have at least one risk factor for CVD, the most
common of which is hypertension (22).
Hypertension is defined as blood pressure (BP) levels ≥140 mmHg systolic and/or ≥90
mmHg diastolic BP, taking antihypertensive medication, or being told by a physician on two
separate occasions a person has high BP (4). Currently, 80 million adults (~32.6%) in the U.S.
have hypertension (22). The lifetime risk for developing hypertension is 90%, and by 2030, it is
estimated that about 41.4% of U.S. adults will have hypertension (22). Moreover, hypertension is
the leading cause of death in women and the second-leading cause of death in men, only behind
smoking (22). From 2003 to 2013, the number of deaths directly related to hypertension in the
U.S. increased by 34.7% (22). Overall, due to the numerous adverse health outcomes associated
with hypertension such as increased risk of stroke, CVD, and kidney failure, many professional
organizations recommend lifestyle interventions such as exercise to prevent, manage, and treat
hypertension (2, 4, 9, 10, 21, 24).
1.2 Exercise and Hypertension
Exercise is recommended by many professional health organizations as a safe and
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effective antihypertensive lifestyle therapy to prevent, manage, and control hypertension (2, 4, 9,
10, 21, 24). The American College of Sports Medicine (ACSM) recommends primarily moderate
intensity (40-<60% maximal oxygen consumption reserve) aerobic exercise on most days of the
week supplemented by moderate intensity [60-80% 1-repetition maximum (1-RM)] resistance
training 2-3 days per week to lower BP 5-7 mmHg among adults with hypertension (2, 24).
Muscular strength and blood pressure
Resistance training has been shown to be beneficial for cardiovascular and metabolic
health (19, 25, 27, 29). In fact, resistance training has risen in popularity as an efficacious mode
of exercise to prevent, manage, and control hypertension (5, 7, 24, 29). For example there are
several epidemiological studies that show the positive association between muscle strength and
BP (3, 17, 20).
Maslow et al. examined the association between muscular strength and hypertension
cases across 19 years in 4,147 men (age, 43 ± 9 years) (20). At baseline 1,951 men had normal
BP [systolic BP (SBP)/diastolic BP (DBP) 108.3 ± 6.7/ 71.4 ± 4.8 mmHg] and 2,196 men had
prehypertension (120.2 ± 8.1/80.4 ± 5.1 mmHg). Subjects were followed from baseline until the
date they were diagnosed with hypertension or until June 30, 2004. Baseline muscular strength
was assessed via a 1-RM supine bench press for upper body strength, and a 1-RM seated leg
press for lower body strength. The authors found a significant relationship (p <0.01) among
hypertension incidence rates across categories of muscle strength. After follow-up, hypertension
rates in those in the high and middle strength categories were 27% and 20% lower than those in
the low muscular strength category, respectively (20). These findings suggest that muscular
strength is inversely associated with the development of hypertension.
Artero et al. examined the impact of muscular strength on mortality in 1,506 men [age,
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50.2 ± 7.4 years; body mass index (BMI), 26.9 ± 3.7] with hypertension (131.7 ± 13.9/89.9 ± 8.5
mmHg) from baseline assessment until their death or until December 31, 2003 (3). Participants
were placed into tertiles based on muscular strength. After controlling for potential confounders
including cardiorespiratory fitness, a higher level of muscular strength was significantly
associated with a lower risk of all-cause mortality in men with hypertension (3). Furthermore
those in the highest strength tertile had a significantly lower risk (~41%) of all-cause mortality
compared to the lower third of muscular strength (3). These results not only support that greater
muscular strength can be protective for the development of hypertension in healthy individuals,
but also can be protective for premature mortality in individuals that already have hypertension
(3).
In addition to the prospective studies above, Lawman et al. examined associations of grip
strength with biomarkers of CVD risk that include serum lipids, plasma insulin, glucose, and BP
in 4,221 participants from the National Health and Nutrition Examination Survey (2011-2012)
(17). On average participants were middle aged (age, 47.5 ± 0.8 years) and had pre-hypertension
(men: 123.1 ± 0.0/72.7 ± 0.6 mmHg); (women: 120.4 ± 0.8/70.6 ± 0.7 mmHg) (17). Isometric
handgrip strength was measured using a hand-held dynamometer while the participant stood with
the arm extended straight down to the side. Three measurements in each hand were recorded and
absolute grip strength was calculated as the sum of the largest reading from each hand (kg).
Relative grip strength was calculated as the absolute grip strength divided by the participant’s
BMI (17). Linear regression models demonstrated a higher relative grip strength was
significantly associated with lower SBP, but not DBP when controlled for BMI (p<0.05) (17).
Overall, the literature supports that higher upper and lower body muscular strength as
measured by 1-RM as well as isometric handgrip strength is inversely associated with BP and the
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development of hypertension (3, 17, 20). A higher muscular strength is also associated with a
decreased incidence rate of early mortality in individuals with hypertension (3). These favorable
associations between muscular strength and BP suggest that there are physiological differences
as it relates to skeletal muscle between those with normal BP vs those with high BP.
1.3 Physiological Alterations in Skeletal Muscle in Those with High versus Normal BP
during a Muscle Contraction
There are several physiological changes that occur in the skeletal muscle during a muscle
contraction that include; an increase in heart rate, sympathetic nerve activity, and BP, regardless
of resting BP status (13). The increase in BP during a muscle contraction is termed the exercise
pressor reflex which is comprised of group III and IV skeletal muscle afferents that are regulated
by mechanical and/or metabolic stimuli (8, 13, 14, 26). There are several studies that sought to
determine differences in these physiological responses to a muscle contraction among those with
high BP compared to individuals with normal BP (8, 12, 16).
Greaney et al. examined the BP and muscle sympathetic nerve activity responses at the
immediate onset of muscle contraction in adults with hypertension as compared to normal BP
(12). Heart rate, BP, and burst frequency (a measure of muscle sympathetic nerve activity) were
measured in 15 individuals with hypertension (age, 62 ± 1 years; BP, 153 ± 3/ 91 ± 5 mmHg)
and 23 individuals with normal BP (age, 60 ± 1 years; BP, 112 ± 1/ 67 ± 2 mmHg) during the
first 30 seconds of isometric handgrip at 30% and 40% of the subjects’ maximal voluntary
contraction (12). For both intensities of handgrip, subjects with hypertension demonstrated a
significantly greater increase in BP and burst frequency from rest within the first 10 seconds of
exercise compared to subjects with normal BP (p<0.05). Greaney et al. concluded that there are
physiological differences in skeletal muscle based on resting BP due to the exaggerated pressor
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response during the onset of exercise in those with hypertension versus those with normal BP
(12).
Delaney et al. aimed to determine the contribution of the metabolic component of the
exercise pressor reflex in response to static exercise in subjects with high versus normal BP (8,
12). Postexercise ischemia was used to trap the metabolites in the forearm produced during
isometric handgrip exercise at 30% and 40% of the subjects’ maximal voluntary contraction (8).
Heart rate, BP, and muscle sympathetic nerve activity were measured at both handgrip intensities
as well as during postexercise ischemia in 23 individuals with normal BP (age, 60 ± 1 years; BP,
112 ± 1/ 67 ± 2 mmHg) and 15 individuals with hypertension (age, 63 ± 1 years; BP, 153 ± 3/ 91
± 5 mmHg) (8). By measuring muscle sympathetic nerve activity during postexercise ischemia,
Delaney et al. was able to assess the influence of the metabolic component of the exercise
pressor reflex, via trapped metabolites in the skeletal muscle. The group with hypertension
exhibited a significantly higher change in mean arterial pressure as well as muscle sympathetic
nerve activity during both 30% and 40% handgrip maximal voluntary contraction and also
during the period of postexercise ischemia (8). Due to the exaggerated sympathetic and pressor
responses to handgrip exercise that were maintained during postexercise ischemia in the group
with hypertension compared to the normal BP group, the authors concluded that the metabolic
component of the exercise pressor reflex is heightened in adults with hypertension (8).
In addition to exaggerated exercise pressor reflex and muscle sympathetic nerve activity,
individuals with high BP also have increased vasoconstriction in the skeletal muscle vasculature
compared to those with normal BP (23, 28). Increases in vasoconstriction and muscle
sympathetic nerve activity ultimately lead to a state of hypoxia in the skeletal muscle due to
having high BP, which further augments oxidative stress (11, 28). These negative physiological
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alterations associated with high BP eventually lead to vascular wall thickening and skeletal
muscle damage (11, 23, 28). Furthermore, during states of hypoxia there is evidence of changes
in skeletal muscle metabolism from oxidative metabolism to an increase in glycolytic
metabolism (11). Accompanying increases in glycolytic metabolism there is also a shift in
skeletal muscle fiber recruitment from Type I to an increase in Type IIb/x muscle fibers due to
hypoxia (11). This shift in muscle metabolism from oxidative to increased glycolytic and muscle
fiber recruitment from Type I to increased Type IIb/x is associated with decreased muscle
strength among those with congestive heart failure and chronic obstructive pulmonary disease
(11).Clearly there are differences in the response to a muscle contraction in those with high BP
vs those with normal BP which may affect muscle strength such as exaggerated exercise pressor
reflex and muscle sympathetic nerve activity as well as increased vasoconstriction and changes
in metabolism and muscle fiber recruitment (8, 12). In addition there is clear evidence showing
an inverse relationship between muscular strength and resting BP, therefore one would assume
an increased resting BP would be associated with decreased muscle strength (3, 17, 20).
However the affect resting BP status has on muscular strength during a single muscle contraction
has not been established.
1.4 Specific Aims and Hypotheses
The purpose of this study was to examine the relationship between resting BP and
measures of muscle strength among healthy men and women distributed equally across the
lifespan. Data for this study was from a larger study entitled, "The Effects of Statins on Muscle
Performance" (STOMP) (NIH RO1 HL081893-01A2).
Specific Aim 1: To assess the relationship between resting BP and baseline muscle strength in
healthy men and women distributed equally across the lifespan.
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Hypothesis 1: Individuals with high BP (pre- to established hypertension) will exhibit decreased
muscle strength during both isometric and isokinetic muscle strength measures compared to
those with normal BP.
Alternative Hypothesis 1: Individuals with high BP will exhibit increased muscle strength
during both isometric and isokinetic muscle strength measures compared to those with normal
BP.
1.5 Significance of Study
Currently, ~32.6% of American adults have hypertension, making it the most prevalent
risk factor for the development for CVD (22). Moreover, of those with hypertension, only 82.7%
were aware of their condition, 76.5% of those who had been diagnosed were being treated, and
only 54.1% are properly controlled to therapeutic levels (SBP < 120 and DBP < 80 mmHg) (22).
Without intervention, the prevalence of hypertension is expected to increase to 41.4% of the U.S.
adult population by 2030, and the total cost related to hypertension is expected to increase from
$48.6 billion to $274 billion (22). Therefore, lifestyle interventions such as exercise including
resistance training should be recommended in order to effectively lower BP among adults with
hypertension (2, 18, 24).
In support of resistance training as an anti-hypertensive therapy, several longitudinal
studies show an inverse relationship between muscular strength and rates of hypertension as well
as mortality in those with hypertension (3, 17, 20). In addition multiple meta-analyses show that
participating in a resistance training program lowers BP and supports the fact that those with
high BP will have lower muscle strength (6, 15). Moreover there is evidence that the
physiological responses to a muscle contraction are different in those with hypertension
compared to those with normal BP, and that changes in muscle metabolism and muscle fiber
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recruitment due to alterations in skeletal muscle vasculature may negatively affect muscle
strength (8, 12, 13). To date no one has directly assessed the relationship between resting BP and
muscle strength. This study could give insight into the affect that resting BP has on skeletal
muscle strength during a single contraction by assessing differences in muscle strength across
resting BP levels.
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2.1 ABSTRACT
Adverse alterations in the skeletal muscle response to exercise have been noted among adults
with hypertension. The influence of resting blood pressure (BP) on muscle strength has not been
examined. PURPOSE: We hypothesized adults with high BP would exhibit lower muscular
strength than adults with normal BP. METHODS: An isokinetic dynamometer tested 21
measures of upper and lower body isometric and isokinetic muscle strength. BP was measured
by auscultation. Subjects were categorized as having normal (<120&<80mmHg) or high
(≥120&/or≥80mmHg) BP. Height (cm) and weight (kg) were measured to calculate body mass
index (BMI,kg∙m-2). Analysis of covariance tested differences in muscle strength between BP
groups with gender, age and BMI as covariates. RESULTS: Subjects (n=420,49% men) were
middle-aged (44.1±16.1yr) and overweight (26.4±4.8kg∙m-2) with 187 having normal
(107.7±7.3/68.3±6.3mmHg) and 233 high (127.8±9.8/80.8±8.1mmHg) BP. For upper body, three
of five extension and five of five flexion measures, as well as handgrip, were greater in the high
than normal BP group (p≤0.05). For lower body, five of five extension measures were greater in
the high than normal BP group, while there were no differences between BP groups for the five
flexion measures (p>0.05). CONCLUSION: Contrary to our hypothesis, adults with high BP
displayed greater muscle strength than adults with normal BP, particularly in the biceps, triceps,
and quadriceps. Reasons for our findings are unclear but may be due to a shift in muscle fiber
type from Type I to Type IIb/x and oxidative to glycolytic metabolism. These alterations would
result in a more strength-adapted phenotype that have been shown to occur in disease states with
altered vascular control as is seen with hypertension.
Key Words: Dynamometer, Exercise, Hypertension, Prehypertension
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2.2 INTRODUCTION
Hypertension is the most common, costly, and preventable cardiovascular disease (CVD)
risk factor with 80 million adults (32.6%) in the United States (U.S.) having hypertension and an
additional 36.3% having prehypertension (20). One in five people with prehypertension will
develop hypertension within 4 year of the diagnosis of prehypertension, and the lifetime risk for
developing hypertension is 90%. By 2030, it is estimated about 41.4% of adults in the U.S. will
have hypertension (20). Adults with high blood pressure (BP) have a higher risk for stroke,
myocardial infarction, and CVD death (20). Due to the significant public health burden of having
high BP, all professional organizations recommend lifestyle interventions such as exercise to
prevent, manage, and treat hypertension (9, 23-25).
Resistance training has been shown to be beneficial for cardiometabolic health, and has
gained in popularity as an efficacious mode of exercise to prevent, manage, and control high BP
(6, 18, 23, 30). Resistance training is reported to elicit BP reductions of 2-3 mmHg among adults
with hypertension (6, 14, 23), and is recommended as an adjuvant lifestyle therapy to aerobic
exercise for its antihypertensive benefits. Interestingly, evidence from epidemiological studies
suggest there is an inverse association between muscle strength and BP (1, 15, 19).
Several primary level studies also exist that show adverse physiological alterations in the
skeletal muscle response to an acute muscle contraction among individuals with hypertension
compared to those with normal BP that includes exaggerated sympathetic nervous activity,
increased vasoconstriction, and a greater release of reactive oxygen species (4, 11, 12, 21, 28).
These alterations create a state of hypoxia in the skeletal muscle which augments oxidative stress
further, eventually leading to vascular wall thickening and skeletal muscle damage (10, 21, 28).
This pathological chain of events has been shown to be associated with decreased muscle
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strength among those with congestive heart failure and chronic obstructive pulmonary disease
(10, 28). Surprisingly, the influence of resting BP status on muscle strength among adults has not
been examined.
Therefore, the purpose of this study was to examine the relationship between resting BP
and measures of muscle strength among healthy, adult men and women equally distributed
across the lifespan. We hypothesized that adults with high BP would exhibit decreased upper and
lower body muscle strength compared to those with normal BP due to the several negative
physiological alterations in the skeletal muscle that is associated with high BP.
2.3 METHODS
Subjects
This study is a sub study from a larger, multi-site, randomized double-blind clinical trial
entitled, Effects of Statins on Skeletal Muscle Function and Performance (STOMP) (NIH Grant
R01HL081893-01A2) (27) that was approved by the Institutional Review Boards of Hartford
Hospital, the University of Massachusetts-Amherst, and the University of Connecticut-Storrs.
All data reported for this STOMP sub study were collected at baseline among 420 healthy men
(49%) and women (51%) equally distributed across the lifespan (ages 20-39 year [n=143], 40-54
year [n=142], and ≥55 year [n=135] with a mean ± standard deviation (SD) age of 44.1 ± 16.1
year and resting systolic BP (SBP)/ diastolic BP (DBP) of 118.9 ± 13.3/ 75.3 ± 9.6 mmHg.
Anthropometrics
Body weight (kg) was measured with a calibrated beam scale, while a wall-mounted tape
measure was used to measure height (m) in order to calculate body mass index (BMI, kg∙m-2)
(23). Waist circumference (cm) was measured using a non-distensible Gulick tape measure (23,
27).
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Blood Pressure
Resting BP was determined according to American Heart Association guidelines (26)
with a Welch Allyn floor sphygmomanometer after subjects were seated for 5 min of rest with
both feet flat on the floor, legs uncrossed, and their back supported. A minimum of two readings,
1 min apart, were taken in each arm at heart level. If there was a >5 mmHg difference between
the first and second readings, additional readings were taken until three measurements agreed
within 5 mmHg. The average of the readings in the non-dominant arm were recorded as resting
BP (27).
Upper and Lower Body Muscle Strength
Dominant isometric handgrip strength was measured using a handgrip dynamometer by
taking the average of three, 3 sec maximal contractions with 1 min rest in between (27). Elbow
isometric and isokinetic flexion/extension and knee flexion/extension in the dominant limb were
measured using a Biodex System 3 dynamometer (Biodex Medical, Shirley, NY) (27). Prior to
each test, participants warmed up by performing three submaximal contractions. For elbow
isometric flexion and extension strength, participants performed three maximal contractions with
the elbow flexed at an angle of 90o. After a 5 min rest, elbow isokinetic flexion and extension
strength were determined by four maximal contractions in succession at 1.05 rad/s or 60o/s
followed by an additional 5 min rest and then four maximal contractions were performed in
succession at 3.14 rad/s or 180o/s. For knee isometric flexion and extension strength, participants
performed three maximal contractions with the knee flexed at an angle of 110o. After 5 min rest,
knee isokinetic flexion and extension strength were determined by four maximal contractions in
succession at 1.05 rad/s or 60o/s followed by an additional 5 min rest and then four maximal
contractions were performed in succession at 3.14 rad/s or 180o/s. The average peak torque (Nm)
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and average power (Nm) was calculated with the Biodex System 3 Software (Biodex Medical,
Shirley, NY) for upper and lower body muscle strength measurements.
Cardiorespiratory Fitness
Cardiorespiratory fitness (i.e., maximal oxygen uptake; VO2max) was assessed using a
breath-by-breath analysis of expired gas via a Parvomedics TrueOne 2400 metabolic cart
(ParvoMedics Corporation, Sandy, Utah). Subjects completed a modified Balke treadmill
protocol after an 8-12 hr fast. Subjects began walking at 2 mph on a 0% incline for 2 min.
Following this warm-up, the treadmill speed was increased to a pace that the subject could
maintain for the remainder of the test, while the treadmill incline increased 1% every min (27).
The test was terminated when one or more of the following conditions were met: the subject
reported a rating of perceived exertion of 18, the subject had a respiratory exchange ratio >1.1,
the subject achieved their age predicted maximum heart rate, there was a plateau in VO2, and/or
the subject self-terminated due to fatigue or discomfort (23, 27).
Statistical Analyses
Muscle strength variables were not normally distributed so that all muscle strength
measures were initially log-transformed for purposes of statistical analysis, and then backtransformed from the mean of the log transform for the purpose of reporting our findings. The
sample was divided by resting BP into two groups: a group with normal BP (SBP <120 mmHg
and DBP <80 mmHg; n=187) and a group with pre- to established hypertension (SBP ≥120
mmHg and/or DBP ≥80 mmHg; n=233). Subject characteristics for the total sample and between
BP groups and gender were tested using one-way analysis of variance (ANOVA). To test the
relationship between resting BP status and baseline muscle strength an ANCOVA was performed
with BP group as a fixed factor and age, gender and BMI as covariates. Statistical significance
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was set at an alpha level of p ≤ 0.05. All analyses were performed using SPSS Statistics 19.0
(IBM Corporation, New York).
2.4 RESULTS
Blood Pressure and Muscle Strength
Subject Characteristics (Table 1)
On average subjects (n=420) were middle-aged, overweight, and had normal BP. The
sample was approximately evenly divided by resting BP status, with 45% having normal BP and
55% having high BP (i.e., pre-hypertension [42%] or established hypertension [13%]). Only 24
(6%) subjects were taking antihypertensive medications. When stratified by resting BP status, the
group with normal BP was younger, and had lower BMI and waist circumference than those with
high BP (p<0.001). Women had a lower BMI, waist circumference, SBP, DBP, and VO2max than
the men (p<0.05). Men were significantly stronger in every measure of muscle strength than the
women (p<0.001).
Isokinetic Muscle Strength Measures at 180o/sec (Table 2)
Upper Body
Of the four isokinetic upper body strength measures performed at 180o/sec, which is an
indicator of predominately Type II muscle fiber recruitment (16), the high BP group had greater
muscular strength for elbow flexion average peak torque (adjusted mean difference ± SD; 1.4 ±
13.2; p=0.01) and elbow flexion average power (0.9 ± 24.7; p<0.001) compared to the normal
BP group. There were no statistically significant differences between BP groups for the two
upper body extension measures (p>0.05).
Lower Body
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Of the four isokinetic lower body strength measures performed at 180o/sec, the high BP
group had greater muscular strength for knee extension average peak torque (6.8 ± 49.5; p=0.02)
and knee extension average power (12.1 ± 99.0; p=0.05) compared to the normal BP group.
There were no statistically significant differences between BP groups for the two lower body
flexion measures (p>0.05).
Isometric Strength Measures and Isokinetic Muscle Strength Measures at 60o/sec (Table 3)
Upper Body
Of the two isometric and four isokinetic upper body strength measures performed at
60o/sec, an indicator of mixed Type I and II muscle fiber recruitment , the high BP group had
greater muscular strength for all elbow strength measures including: isometric extension average
peak torque (0.0 ± 24.7; p=0.02); isometric flexion average peak torque (1.4 ± 26.3; p<0.001);
extension average peak torque (1.1 ± 17.5; p=0.02); flexion average peak torque (0.3 ± 14.6;
p=0.01); extension average power (1.2 ± 14.6; p<0.001); and flexion average power (0.2 ± 13.2;
p<0.001) compared to the normal BP group. In addition, handgrip strength (1.1 ± 17.4; p<0.001)
was greater in the high BP group compared to the normal BP group.
Lower Body
Of the two isometric and four isokinetic lower body strength measures performed at
60o/sec, the high BP group had greater muscular strength for all knee extension measures
including: isometric extension average peak torque (14.1 ± 96.1; p=0.01); extension average
peak torque (6.8 ± 62.6; p=0.02); and extension average power (5.3 ± 46.6; p<0.001). There were
no differences between BP groups for the three knee flexion measures (p>0.05).
2.5 DISCUSSION
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The present study examined the relationship between resting BP and muscle strength
among healthy adults across the lifespan, of which 45% had normal BP and 55% had high BP.
We hypothesized that individuals with high BP would exhibit reduced muscle strength compared
to those with normal BP. Unexpectedly, we found that adults with pre- to established
hypertension generally had greater muscle strength than those with normal BP in the biceps,
triceps, and quadriceps as well as handgrip. More specifically, the high BP group had greater
muscle strength on four out of the eight upper and lower body isokinetic measures performed at
180o/sec, a speed of contraction that reflects Type II muscle fiber recruitment (16); all extension
and flexion upper body isometric measures, six out of eight upper and lower body isokinetic
measures performed at 60o/sec, a speed of contraction that reflects mixed Type I and Type II
muscle fiber recruitment; and one out of two lower body isometric measures. Our unanticipated
findings suggest that otherwise healthy adults in the early stages of hypertension have a more
muscle strength adapted phenotype than adults with normal BP.
Our findings are consistent with those of Dong et al. who recently examined the
association between handgrip strength and resting BP in 44,240 adolescent boys (mean ± SD;
15.0 ± 1.4 yr) and 44,625 adolescent girls (15.0 ± 1.4 yr) with normal BP (8). Adolescents were
stratified by BMI as being thin, normal, overweight, or obese according to sex- and age-specific
normative values (5). Dong et al. (8) found a positive relationship between handgrip strength and
resting BP after stratifying by and/or adjusting for BMI in the adolescents (p ≤ 0.05).
Several primary level studies exist that may lend support and mechanistic insight into our
findings and those of Dong et al. (8). There are physiological differences in the structure and
function of the skeletal muscle during exercise in those with high compared to normal BP that
may affect muscle strength (4, 7, 11, 13, 17). For example, there is evidence showing vascular
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function in the skeletal muscle is impaired during exercise with high BP (29). Vongpatanasin et
al. sought to examine if functional sympatholysis is impaired among otherwise healthy 13 middle
aged men and women with hypertension (SBP/DBP, 144 ± 4/ 87 ± 2 mmHg) compared to 17
middle aged men and women with normal BP (SBP/DBP, 118 ± 3/ 72 ± 2 mmHg) (29). They
measured muscle oxygenation and forearm blood flow in response to increases in sympathetic
nerve activity evoked by lower body negative pressure at rest and during moderate intensity
handgrip exercise (29). Among the subjects with hypertension, the ability to combat the increase
in sympathetic vasoconstriction during acute moderate intensity via functional sympatholysis
was blunted compared to the subjects with normal BP limiting the blood flow and oxygen
delivery to the working skeletal muscles.
Similarly Nyberg et al. examined leg blood flow regulation and oxygenation before and
after eight weeks of aerobic training among 10 middle aged adults with hypertension (SBP/DBP,
183 ± 7/ 101 ± 5 mmHg) compared to 11 middle aged adults with normal BP (SBP/DBP, 119 ±
4/ 70 ± 2 mmHg) (22). At baseline, those with hypertension had decreased leg blood flow and
oxygen delivery compared to the normal BP group during 10, 20, and 30 watts of knee-extensor
exercise (p ≤ 0.05) (22). Overall Nyberg et al. (22) findings support those of Vongpatanasin et al.
(29) such that during acute bouts of resistance exercise oxygen delivery to the working skeletal
muscles is reduced in those with high BP compared to those with normal BP.
There is further evidence of alterations in skeletal muscle metabolism and muscle fiber
type recruitment during acute resistance exercise in individuals with high BP. Several
investigative teams have found that there is a shift from oxidative to glycolytic metabolism under
hypoxic conditions in the skeletal muscle in individuals with high BP (3, 10, 13, 21). The
increased reliance on glycolytic metabolism can result in a shift in muscle fiber type recruitment
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from Type I to an increase in Type IIb/x that has been documented in disease states such as
chronic obstructive pulmonary disease and chronic heart failure (10). In addition, there is
evidence demonstrating differences in hormonal responses to having high BP versus normal BP
(2). Batool et al. (2) found women with hypertension had higher levels of testosterone compared
to women with normal BP. Collectively, these findings provide mechanistic insight into our
findings of a more muscle strength adapted phenotype among adults with high than normal BP.
There were limitations to our study. Our investigation was a sub study of the larger
STOMP clinical trial (NIH Grant R01HL081893-01A2) so that the data collected in the larger
STOMP study were not intended to test the hypothesis of this sub study. This sub study was not
mechanistic in nature so that we can only speculate on reasons for our unanticipated findings.
Measurements such as muscle biopsies or testing muscle strength at higher and lower isokinetic
speeds than 60o/sec and 180o/sec could have given more information about our speculation into
muscle fiber recruitment. Additional measurements such as electromyography, magnetic
resonance imaging, ultrasound, and muscle sympathetic nervous activity could have added a
more comprehensive picture of muscular architecture and neural activation associated with
having high BP, and how these changes may have affected muscle strength. Last, the
associations we found among high resting BP and 14 out of 21 measures of upper and lower
body muscle strength, although provocative, do not demonstrate causality. Strengths of our sub
study include a large sample of 420 healthy adults evenly distributed across the lifespan that
allowed us to account for BMI in our statistical analyses, an important confounding factor to
consider in the association between resting BP and muscle strength. The larger STOMP methods
used gold standard measurement protocols for both resting BP (26) and upper and lower body
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muscle strength. Also, subjects were absent of chronic disease or health conditions other than
high BP that could have confounded our muscular strength outcomes.
To conclude, we found that multiple dimensions of upper and lower body muscle strength
were greater among adults with pre- to established hypertension than adults with normal BP.
Future studies are needed to confirm our findings, and if confirmed, investigate possible
mechanisms to explain the influence high BP may have on muscle strength among adults in the
early stages of hypertension.
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2.7.1 Table 1. Baseline characteristics (Mean ± SD) for the total sample and by resting blood pressure status and gender
Total
Men
Women
Normal BP
High BP
Variable
(n=420)
(n=204)
(n= 216)
(n=187)
(n=233)
Age (yr)
44.1 ± 16.1
43.7 ± 15.8
44.5 ± 16.5
41.0 ± 15.6
46.61 ± 16.2‡
-2
BMI (kg·m )
26.4 ± 4.8
27.4 ± 4.5
25.5 ± 5.0**
25.3 ± 4.2
27.3 ± 5.1‡
WC (cm)
86.2 ± 13.9
92.8 ± 13.0
80.3 ± 12.0**
82.5 ± 12.5
89.2 ± 14.3‡
Systolic BP (mmHg)
118.9 ± 13.3
121.7 ± 12.7
116.3 ± 13.3**
107.7 ± 7.3
127.8 ± 9.8‡
Diastolic BP
75.3 ± 9.6
76.4 ± 9.4
74.1 ± 9.8*
68.3 ± 6.3
80.8 ± 8.1‡
(mmHg)
Maximal oxygen
33.9 ± 9.7
38.2 ± 8.9
29.9 ± 8.8**
34.7 ± 9.5
33.3 ± 9.9
uptake (ml·kg·min-1)
Note: Abbr. BMI= body mass index; BP= blood pressure; WC= waist circumference, SD= standard deviation
Gender difference, * p≤ 0.05, ** p≤ 0.001; resting BP Status difference, ‡p≤ 0.001
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2.7.2 Table 2. Adjusted baseline muscle strength measures performed at 180o/sec+
(Adjusted Mean ± SD) by resting blood pressure status
Normal BP

High BP

(n=187)

(n=233)

Isokinetic Extension1

31.1 ± 6.9

32.4 ± 7.7

Isokinetic Flexion1

29.6 ± 6.9

31.0 ± 6.1**

Isokinetic Extension2

56.7 ± 16.4

59.3 ± 16.8

Isokinetic Flexion2

49.4 ± 12.3

50.3 ± 12.2**

Isokinetic Extension1

96.0 ± 24.7

102.8 ± 24.5*

Isokinetic Flexion1

52.7 ± 15.1

55.8 ± 15.3

Isokinetic Extension2

175.9 ± 49.3

188.0 ± 49.0*

Isokinetic Flexion2

90.7 ± 34.3

96.6 ± 35.2

Muscle Strength Measures at 180o/sec

Upper Body (N-M)

Lower Body (N-M)

Note: Normal vs High BP status adjusted for age, gender, and BMI, * p ≤ 0.05,
** p ≤ 0.01. +Accurate predictor of Type II muscle fiber recruitment; 1 average peak torque;
2

average power; BP, blood pressure.
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2.7.3 Table 3. Adjusted baseline isometric and isokinetic muscle strength measure performed at 60o/sec
(Adjusted Mean ± SD) by resting blood pressure status
Normal BP

High BP

(n=187)

(n=233)

38.8 ± 8.2

39.9 ± 9.2**

Isometric Extension1

44.1 ± 12.3

44.1 ± 12.2*

Isometric Flexion1

51.5 ± 13.7

52.9 ± 12.2**

Isokinetic Extension1

38.7 ± 8.2

39.8 ± 9.2*

Isokinetic Flexion1

34.5 ± 6.9

34.8 ± 7.7**

Isokinetic Extension2

29.2 ± 6.9

30.4 ± 7.7**

Isokinetic Flexion2

26.1 ± 6.9

26.3 ± 6.1**

Isometric Extension1

182.9 ± 48.0

197.0 ± 47.4**

Isometric Flexion1

80.2 ± 19.2

83.9 ± 19.9

Isokinetic Extension1

143.7 ± 31.5

150.5 ± 30.6*

Isokinetic Flexion1

75.1 ± 19.2

77.6 ± 19.9

Isokinetic Extension2

98.7 ± 23.3

104.0 ± 23.0**

Isokinetic Flexion2

55.6 ± 13.7

56.5 ± 13.8

Muscle Strength Measures

Handgrip (kg)
Upper Body (N-M)

Lower Body (N-M)

Note: Normal vs High BP status adjusted for age, gender, and BMI,
* p ≤ 0.05, ** p ≤ 0.01. 1 average peak torque; 2 average power; BP, blood pressure.
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Chapter 3. Methods
The present study is a sub study from a larger, multi-site, randomized double-blind
clinical trial entitled, Effects of Statins on Skeletal Muscle Function and Performance (STOMP)
(NIH RO1 HL081893-01A2). STOMP was approved by the Institutional Review Boards of
Hartford Hospital, the University of Massachusetts-Amherst, and the University of ConnecticutStorrs (9). Written consent was obtained from all participants. The specific aims of STOMP were
to examine the incidence rate of statin-induced myalgia and the effects of statins on muscle
strength, endurance, and aerobic exercise performance in a healthy population taking 80 mg
Atorvastatin or a placebo (9). Data used for the present study were collected at baseline prior to
randomization to either a placebo or 80 mg of Atorvastatin among 204 healthy males and 216
females distributed equally across the lifespan with a mean ± standard deviation (SD) age of 44.1
± 16.1 years (6).
3.1 Subject Recruitment: Inclusion and Exclusion
A total of 468 subjects were recruited over 4 years at three sites (Hartford Hospital,
University of Massachusetts, and University of Connecticut) and were equally distributed into 3
age groups (20-39, 40-54, and >55 year) (6, 9). Subjects were excluded for the following
reasons; 1) cancer diagnosis within 5 years, 2) renal disease (creatinine level >2 mg/L), 3)
hepatic disease (alanine amino-transferase value >2 times the upper limit of normal), 4)
abnormal thyroid-stimulating hormone level, 5) history of CVD, 6) abnormal or ischemicappearing ECG during exercise, 7) diabetes mellitus, 8) subjective muscle complaints or
weakness, 9) physical disabilities that would inhibit exercise testing, and 10) present or previous
treatment with lipid lowering medications, or medications that would alter statin metabolism (6,
9). Women who were pregnant or planning to become pregnant were excluded. All women in the
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study of child-bearing age agreed to use an established method of birth control throughout.
Lastly, subjects with hypertension were included if their BP was controlled and ≤140/90 mmHg
at baseline (9). During the study, subjects were removed if their creatine kinase exceeded 10
times the upper limit of normal at any point or if their alanine amino-transferase exceeded 3
times the upper limit of normal on 2 measurements performed within 1 week of the first elevated
value (6).
3.2 Study Overview
The study consisted of six visits over ~6 months. Prior to the first visit, if a potential
subject expressed interest, a phone interview was performed to determine if the subject met the
inclusion and exclusion criteria. If the subject met the eligibility, they attended an orientation
session which was deemed visit 1 (V1) (9).
V1 involved the informed consent process, measurement of vital signs and
anthropometrics, a brief physical examination by a physician, strength testing of the elbow, knee
and handgrip, and a Bruce Protocol maximal treadmill exercise test to exclude those with
documented cardiac ischemia (3). A fasting blood sample was taken for measurement of lowdensity lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), triglycerides,
25-hydroxy vitamin D, thyroid-stimulating hormone, alanine aminotransferase (ALT), creatinine,
creatine kinase (CK), and creatine kinase MB (CKMB). Lastly subjects completed several
surveys including the Paffenbarger Physical Activity questionnaire, the Short-Form McGill Pain
questionnaire, and the Brief Pain Inventory (Short Form) (9).
Approximately 72 hr after the completion of V1 subjects completed visit 2 (V2). During
V2 subjects performed strength testing via the Biodex System 3 Isokinetic Dynamometer
(Biodex Medical, Shirley, NY) of the elbow and knee, as well as endurance testing of the knee.
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A handgrip dynamometer was used to assess handgrip strength. Next, another maximal treadmill
exercise test was performed, this time following a modified Balke protocol to assess VO2max (1).
After testing, subjects left the site with an Actical PA accelerometer (Mini Meter, a Respironics
Inc., Bend, OR) which was worn for 96 consecutive hours to assess PA levels (9).
Visit 3 (V3) was performed at least 96 hours following V2 in order to obtain the Actical
accelerometer data. Subjects then completed another assessment of muscle strength of the elbow
and knee as well as handgrip. During V3, subjects were randomized to either Atorvastatin 80mg
or placebo group in which a 3 month supply was dispensed. This visit was deemed week 0. Prior
to visit 4 (V4), subjects received a telephone call from study investigators at weeks 2, 4, 6, 8, and
10 in order to assess medication compliance and any symptoms or adverse events (9).
Subjects returned to the testing site at week 12 for V4. A fasting blood draw was taken
for measurement of ALT, CK, and CKMB. Medication compliance and any symptoms or
adverse events were also assessed. During V4, a second 3 month medication supply was
dispensed. After V4 subjects received phone calls from investigators at weeks 14, 16, 18, 20, and
22 in which medication compliance and any symptoms or adverse events were assessed (9).
Subjects returned to the testing site at week 24 which was visit 5 (V5). A fasting blood
draw was taken for measurement of LDL, HDL, triglycerides, ALT, creatinine, CK, CKMB, and
vitamin D. Vital signs and anthropometric measures were taken as well as another measure of
muscle strength of the elbow and knee and handgrip. Subjects’ VO2max was assessed by
performing a maximal graded exercise treadmill test using the modified Balke protocol (1).
Subjects also completed the Paffenbarger physical activity questionnaire, the Short-Form McGill
Pain questionnaire, and the Brief Pain Inventory (Short Form) (4, 5, 8). Lastly, subjects left V5
wearing the Actical accelerometer for another 96 hours (9).

34

The last visit was visit 6 (V6) approximately 96 hours after V5. The Actical data was
downloaded while subjects performed another strength testing of the elbow and knee as well as
handgrip (9).
3.3 Anthropometric Measurements
This sub-study used baseline anthropometrics measured at V1. Subjects' body weight
(kg) was measured by a calibrated beam scale. A wall-mounted tape measure was used to
measure height (in), after the removal of shoes and any heavy clothing, to calculate body mass
index (BMI) (kg∙m-2). Waist circumference (cm) was measured with a Gulick spring-loaded nondispensable tape measure (Sammons Prestion, Chicago, IL) at the narrowest part of the torso
above the umbilicus and below the xiphoid process while the subject stood with their arms at
their sides, feet together, and abdomen relaxed (1, 9). The average of two measurements were
recorded, provided the measurements were within 5 mm of one another. If the two measurements
were not within 5 mm of one another, the study investigator continued to take waist
circumference measurements until there were two measurements that were within 5 mm of one
another and these were averaged (9).
3.4 Muscle Strength
Muscle strength was measured through different measures including handgrip strength,
elbow and knee flexion and extension. Strength testing during V1 was used to familiarize the
subject with the equipment and the protocol used, and the strength measures from V2 and V3
were averaged and recorded (9). The average strength measures from V2 and V3 were taken
prior to randomization and these measures were used in this sub-study.
Isometric handgrip strength was performed using a handgrip dynamometer. Subjects
completed three maximal contractions in the dominant hand lasting 3 seconds each, seated with
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the elbow flexed at 90 degrees. A total of three trials were performed with 1 minute of rest in
between each contraction. The three trials were averaged and recorded in kg (9).
Elbow flexion/extension and knee flexion/extension isometric and isokinetic tests were
measured using the Biodex System 3 Isokinetic Dynamometer (Biodex Medical, Shirley, NY)
(9). Subjects warmed up by performing three submaximal contractions prior to each test.
For elbow isometric strength, subjects performed three isometric contractions for both
flexion and extension with the elbow fixed at 90 degrees. Subjects were given a 1 minute rest in
between each contraction. After 5 minutes of rest, elbow isokinetic strength was measured by
first having the subjects perform four contractions at 1.05 rad/s (60 deg/s). After an additional 5
minutes of rest subjects performed four isokinetic contractions at 3.14 rad/s (180 deg/s) (9).
Average peak torque and average power (Nm) was recorded.
For knee isometric strength, subjects performed three isometric contractions for both
flexion and extension with the knee fixed at 110 degrees. Subjects were given a 1 minute rest in
between each contraction. After 5 minutes of rest, knee isokinetic strength was measured by
having the subjects perform four contractions at 1.05 rad/s (60 deg/s) followed by another 5
minutes of rest. Then subjects performed four isokinetic contractions at 3.14 rad/s (180 deg/s)
(9). Average peak torque and average power (Nm) was recorded (9).
3.5 Resting Blood Pressure
Resting blood pressure (BP) was determined according to American Heart Association
guidelines with a Welch Allyn floor manual sphygmomanometer after subjects were seated for 5
minutes of rest with both feet flat on the floor, legs uncrossed, and their back supported (7). A
minimum of two readings were taken in each arm at heart level. If there was a >5 mmHg
difference between the first and second readings, additional readings were taken until three
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measurements agreed within 5 mmHg and were averaged. The first and last audible sounds were
recorded as systolic (SBP) and diastolic (DBP) pressure, respectively (7, 9).
3.6 Cardiorespiratory Fitness (VO2max)
The cardiorespiratory fitness (VO2max) data that was used for this sub-study was recorded
at baseline from V2. VO2max was assessed using a breath-by-breath analysis of expired gases by
the Parvomedics True One 2400 Metabolic Cart (ParvoMedics Corp, Sandy, UT) (9). Prior to the
start of the test subjects sat quietly for 5 minutes in order to ensure resting conditions. The
subject then began to walk on the treadmill at 2 miles per hour with a 0% incline for 2 minutes.
After choosing a speed that the subject could maintain comfortably throughout the remainder of
the test, the treadmill incline increased 1% every minute following the initial 2 minute walk. BP,
heart rate, and rating of perceived exertion (RPE) was measured throughout the test (2, 9). The
test was terminated when one or more of the following conditions were met: the subject reported
a RPE of 18, the subject had a respiratory exchange ratio greater than 1.1, the subject achieved
their age predicted maximum heart rate, there was a plateau in oxygen uptake, and/or the subject
self-terminated due to fatigue or discomfort (1, 9).
3.7 Data Administration
Data collected during STOMP was compiled into an online master database, which was
maintained by the study coordinator at Hartford Hospital. Investigators from the three study sites
manually entered STOMP data into the online database. The master database was only accessed
by study personnel and was secured by confidential usernames and passwords (6).
3.8 Statistical Analyses
All statistical analyses were performed using SPSS Statistics 19.0 (IBM Corporation,
New York). Since muscle strength variables were not normally distributed, all muscle strength
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measures were log-transformed for analyses. For variables that were log transformed, the mean
outcome was then back-transformed from the mean of the log transform for ease of clinical
interpretation. For analyses, subjects were broken into two groups based on BP status: a group
with normal BP (SBP <120 mmHg and DBP <80 mmHg; n=187) and a group with pre- to
established hypertension (SBP ≥120 mmHg and/or DBP ≥80 mmHg; n=233). Subject descriptive
statistics between genders and BP status were compared using one-way analysis of variance
(ANOVA). Subject descriptive results are displayed as mean ± standard deviation (SD). To
determine the relationship between BP and baseline muscle strength an ANCOVA was
performed while controlling for age, gender, and BMI. All two-way interactions between
variables were used in the ANCOVA models. Non-significant interactions were individually
removed until only significant interactions remained in the model. Muscle strength results are
displayed as mean ± standard deviation (SD). Statistical significance was set at an alpha level of
p ≤ 0.05.
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Chapter 4. Discussion
The primary purpose of this thesis was to examine the relationship between resting BP
and muscle strength. We sought to examine this relationship by testing the influence of resting
BP on 21 measures of upper and lower body muscle strength in 420 healthy adults across the
lifespan, of which 45% had normal BP and 55% had high BP. Initially the specific aims and
hypotheses will be discussed followed by a summary of significant findings. I will then discuss
methodological considerations, specifically related to the scientific method that may have led to
our unexpected findings and how our findings add to the current literature. Finally, directions for
future research pertaining to the findings will be suggested.
4.1 Specific Aims and Hypothesis
Specific Aim 1: To examine the relationship between resting BP and measures of muscle strength
among healthy, adult men and women equally distributed across the lifespan.
Hypothesis 1: Adults with high BP would exhibit decreased upper and lower body muscle
strength compared to those with normal BP. Contrary to our hypothesis we found adults with
high BP had greater muscle strength than those with normal BP. The high BP group had greater
muscle strength on four out of the eight upper (p ≤ 0.01) and lower body (p ≤ 0.05) isokinetic
measures performed at 180o/sec, all extension and flexion upper body isometric measures (p ≤
0.05), six out of eight upper and lower body isokinetic measures performed at 60o/sec (p ≤ 0.05),
and one out of two lower body isometric measures (p ≤ 0.01). Those with high BP appear to
generally have a higher muscle strength phenotype than those with normal BP, particularly in the
biceps, triceps, and quadriceps as well as handgrip.
4.2 Methodological Considerations: Importance of Implementing the Scientific Method
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I examined methodological considerations and aspects of the scientific method to explain
our unexpected findings. First, with the help of a medical librarian, I performed a literature
search to locate available evidence on muscle strength and BP. Reference lists of qualified trials
from the literature review were searched for additional studies of interest. Trials located by the
search included the relationship between cardiovascular risk factors, specifically BP, and muscle
strength among adults. These trials consistently demonstrated an inverse relationship between
muscular strength and BP, in that higher muscle strength was associated with having a lower
resting BP as well as associated with a delay in early mortality (1, 4, 5, 12). Also the negative
effects of having high BP on skeletal muscle physiology and in turn exercise performance were
apparent due to evidence of increases in the exercise pressor reflex, sympathetic nerve activity,
and decreases in blood flow and oxygen delivery during a muscle contraction (3, 6, 9).
Therefore, I formulated my hypothesis that adults with high BP would exhibit decreased
muscular strength on the limited but available evidence in the literature.
Nonetheless, we found unexpected results that did not align with our initial hypothesis.
We found adults with high BP generally had an increased muscle strength compared to those
with normal BP. These are unexpected results because the literature we searched showed there
exists an inverse relationship between BP and muscular strength. Also it is known the negative
effects from having high BP reduces exercise capacity and more specifically skeletal muscle
function (3, 7). As a result, there is a question as to what possible mechanisms would explain the
positive association between resting BP and muscle strength that we found. Therefore we then
had to perform an additional literature search in order to find evidence that might support our
novel findings. Ultimately we found there alterations such as decreased blood flow and oxygen
delivery to working skeletal muscles in those with high BP compared to those with normal BP,

42

which creates a state of hypoxia in the skeletal muscle (8, 11). Due to the state of hypoxia, there
is some evidence suggesting a shift in muscle fiber type recruitment from Type I to Type IIb/x as
well as a shift in energy metabolism from oxidative to an increase in glycolytic, creating an
increased muscle strength adapted phenotype (3, 7). Now we as well as other authors are able to
form addition questions and hypothesis based on our unexpected results and proposed
mechanisms.
4.3 Impact on the Current Literature
To our knowledge, this is the first study to directly assess the impact of resting BP on
muscle strength in healthy adults distributed across the lifespan. We are the first to show that
adults with pre- to established hypertension exhibited an increased muscle strength in the upper
and lower body compared to adults with normal BP. However, there is recent evidence that this
positive relationship exists in adolescents with normal BP. Dong et al. (2) examined the
association between BP and handgrip strength in 44,240 adolescents boys (mean ± SD; 15.0 ±
1.4 yr) and 44,625 adolescent girls (15.0 ± 1.4 yr) with normal BP. After subjects were stratified
by BMI into thin, normal, overweight, or obese Dong et al. (2) found that those with a higher
resting BP displayed a higher muscular strength. This positive relationship existed after adjusting
for BMI across both genders in the entire sample, as well as across BMI groups after
stratification. This supports our findings albeit in a generally healthy adolescent population with
normal BP (2).
In addition there is evidence of physiological alterations in the skeletal muscle of those
with high compared to normal BP both at rest and during acute exercise that may affect muscle
strength (6, 7, 10). However, none of these studies have examined the influence of BP on muscle
strength directly, but rather what changes in skeletal muscle physiology and function exist
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between individuals with normal compared to high BP. For example Vongpatanasin et al.
(11)examined the difference in functional sympatholysis, via muscle oxygenation and forearm
blood flow, among 13 middle aged men and women with hypertension compared to 17 middle
aged men and women with normal BP. They found subjects with hypertension had a decreased
muscle oxygenation and forearm blood flow, which was limited by an impaired functional
sympatholysis compared to those with normal BP (11). Ultimately due to the decrease oxygen
availability to working skeletal muscle, there is an increased reliance of glycolytic metabolism
and in turn an increase recruitment of Type II muscle fibers.
Overall evidence exists that shows a positive association between resting BP and muscle
strength in adolescents, as well as physiological changes that may influence a stronger muscle
strength adapted phenotype in those with high BP compared to normal BP. Nonetheless, we were
the first to examine and show that healthy adults distributed equally across the lifespan with high
BP generally had an increased muscle strength compared to those with normal BP. Due to our
unexpected and novel results, future studies are warranted to confirm this positive association as
well as measure potential mechanisms.
4.4 Future Research
This thesis provides evidence that adults with high BP generally showed an increased
muscle strength in both the upper and lower body. Potential mechanisms behind these
unexpected findings were not measured and therefore can only be speculated at this time. Thus,
future studies should assess the impact of resting BP on muscular strength while measuring
potential mechanisms gaining insight into these relationships.
Also this study included otherwise healthy adults with the majority having
prehypertension in the high BP group. Future studies should examine the relationship between
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resting BP and muscle strength among equal numbers of individuals with normal BP,
prehypertension, and hypertension to establish if there are potential differences in muscle
strength among BP status.
4.5 Conclusion
To our knowledge we are the first to show that adults free from cardiovascular disease or
conditions distributed across the lifespan demonstrated an increased muscular strength in the
upper and lower body compared to adults with normal BP. Therefore future studies are needed to
confirm our original findings, and also investigate possible mechanisms into why adults in the
early stages of hypertension have an increased muscular strength during an acute muscle
contraction.
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